Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
17 April 2023 |
Main ID: |
NCT03585946 |
Date of registration:
|
14/03/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
|
Scientific title:
|
A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis |
Date of first enrolment:
|
January 1, 2024 |
Target sample size:
|
750 |
Recruitment status: |
Not yet recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03585946 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- a diagnosis of Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis confirmed by
examination of a dermatologist and/or skin biopsy plus described appropriate clinical
findings (epidermal necrosis plus two involved mucosal surfaces) presenting within one
week of disease onset
Exclusion Criteria:
- Pregnancy
- Age <18y
- Decisional impairment
- Incarceration
- Onset of skin separation >7d
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Stevens-Johnson Syndrome
|
Toxic Epidermal Necrolysis
|
Drug Reaction
|
Intervention(s)
|
Drug: Site specific standard of care comparison
|
Primary Outcome(s)
|
Hospital length of stay
[Time Frame: 3 years]
|
Mortality
[Time Frame: 3 years]
|
Time to cessation of new lesion formation
[Time Frame: 3 years]
|
Time to re-epithelialization
[Time Frame: 3 years]
|
Secondary ID(s)
|
P201700P002792
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|